IPI-549-01-A phase 1/1b first in human study of IPI-549, a PI3K-gamma inhibitor, as monotherapy and in combination with pembrolizumab in subjects with advanced solid tumors Meeting Abstract
| Authors: | Tolcher, A. W.; Hong, D. S.; Sullivan, R. J.; Mier, J. W.; Shapiro, G.; Pearlberg, J.; Brail, L. H.; Kharidia, J.; Han, L.; Ullmann, C. D.; Stern, H. M.; Wolchok, J. D. |
| Abstract Title: | IPI-549-01-A phase 1/1b first in human study of IPI-549, a PI3K-gamma inhibitor, as monotherapy and in combination with pembrolizumab in subjects with advanced solid tumors |
| Meeting Title: | 52nd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 34 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2016 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2016-05-20 |
| Start Page: | 169s |
| Language: | English |
| ACCESSION: | WOS:000404665404148 |
| DOI: | 10.1200/JCO.2016.34.15_suppl.TPS3111 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TPS3111 -- Source: Wos |
